{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:55Z","timestamp":1791260635371,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41401-021-00633-4","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T16:03:18Z","timestamp":1617033798000},"page":"146-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["PXR mediates mifepristone-induced hepatomegaly in mice"],"prefix":"10.1038","volume":"43","author":[{"given":"Xin-peng","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ying","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-cheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-chang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"633_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/scientificamerican0690-42","volume":"262","author":"A Ulmann","year":"1990","unstructured":"Ulmann A, Teutsch G, Philibert D. RU 486. Sci Am. 1990;262:42\u20138.","journal-title":"Sci Am"},{"key":"633_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0015-0282(16)54527-0","volume":"56","author":"OM Avrech","year":"1991","unstructured":"Avrech OM, Golan A, Weinraub Z, Bukovsky I, Caspi E. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review. Fertil Steril. 1991;56:385\u201393.","journal-title":"Fertil Steril"},{"key":"633_CR3","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/med.21311","volume":"34","author":"J Chen","year":"2014","unstructured":"Chen J, Wang J, Shao J, Gao Y, Xu J, Yu S, et al. The unique pharmacological characteristics of mifepristone (RU486): from terminating pregnancy to preventing cancer metastasis. Med Res Rev. 2014;34:979\u20131000.","journal-title":"Med Res Rev"},{"key":"633_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1749-6632.1995.tb31385.x","volume":"761","author":"CM Bamberger","year":"1995","unstructured":"Bamberger CM, Chrousos GP. The glucocorticoid receptor and RU 486 in man. Ann N Y Acad Sci. 1995;761:296\u2013310.","journal-title":"Ann N Y Acad Sci"},{"key":"633_CR5","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, et al. Treatment of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:2807\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"633_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tox.2003.12.018","volume":"199","author":"LA Vignati","year":"2004","unstructured":"Vignati LA, Bogni A, Grossi P, Monshouwer M. A human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A induction. Toxicology. 2004;199:23\u201333.","journal-title":"Toxicology."},{"key":"633_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/15376516.2015.1118715","volume":"26","author":"Y Xiao","year":"2016","unstructured":"Xiao Y, Zhu Y, Yu S, Yan C, Ho RJ, Liu J, et al. Thirty-day rat toxicity study reveals reversible liver toxicity of mifepristone (RU486) and metapristone. Toxicol Mech Methods. 2016;26:36\u201345.","journal-title":"Toxicol Mech Methods"},{"key":"633_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.biopha.2016.01.017","volume":"78","author":"J Wang","year":"2016","unstructured":"Wang J, Chen J, Zhu Y, Zheng N, Liu J, Xiao Y, et al. In vitro and in vivo efficacy and safety evaluation of metapristone and mifepristone as cancer metastatic chemopreventive agents. Biomed Pharmacother. 2016;78:291\u2013300.","journal-title":"Biomed Pharmacother"},{"key":"633_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/0192623312448935","volume":"40","author":"AP Hall","year":"2012","unstructured":"Hall AP, Elcombe CR, Foster JR, Harada T, Kaufmann W, Knippel A, et al. Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes\u2013conclusions from the 3rd International ESTP Expert Workshop. Toxicol Pathol. 2012;40:971\u201394.","journal-title":"Toxicol Pathol"},{"key":"633_CR10","unstructured":"Andrew D. PSD Guidance Document. Interpretation of liver enlargement in regulatory toxicity studies, 2005. https:\/\/webarchive.nationalarchives.gov.uk\/20121031084609\/http:\/\/www.pesticides.gov.uk\/Resources\/CRD\/Migrated-Resources\/Documents\/A\/ACP_Paper_on_the_interpretation_of_Liver_Enlargement.pdf."},{"key":"633_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","volume":"126","author":"AL Bookout","year":"2006","unstructured":"Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell. 2006;126:789\u201399.","journal-title":"Cell."},{"key":"633_CR12","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1210\/me.2004-0520","volume":"19","author":"W Huang","year":"2005","unstructured":"Huang W, Zhang J, Washington M, Liu J, Parant JM, Lozano G, et al. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol. 2005;19:1646\u201353.","journal-title":"Mol Endocrinol"},{"key":"633_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jemt.10327","volume":"61","author":"RC Cattley","year":"2003","unstructured":"Cattley RC. Regulation of cell proliferation and cell death by peroxisome proliferators. Microsc Res Tech. 2003;61:179\u201384.","journal-title":"Microsc Res Tech"},{"key":"633_CR14","doi-asserted-by":"publisher","first-page":"e61802","DOI":"10.1371\/journal.pone.0061802","volume":"8","author":"R Shizu","year":"2013","unstructured":"Shizu R, Benoki S, Numakura Y, Kodama S, Miyata M, Yamazoe Y, et al. Xenobiotic-induced hepatocyte proliferation associated with constitutive active\/androstane receptor (CAR) or peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) is enhanced by pregnane X receptor (PXR) activation in mice. PLoS ONE. 2013;8:e61802.","journal-title":"PLoS ONE"},{"key":"633_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000144380","volume":"91","author":"BD Garg","year":"1975","unstructured":"Garg BD, Kovacs K, Tuchweber B, Khandekar JD. Effect of pregnenolone-16alpha-carbonitrile, a microsomal enzyme inducer, on the regenerating rat liver. Acta Anat (Basel). 1975;91:161\u201374.","journal-title":"Acta Anat (Basel)"},{"key":"633_CR16","first-page":"1467","volume":"29","author":"J Staudinger","year":"2001","unstructured":"Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos. 2001;29:1467\u201372.","journal-title":"Drug Metab Dispos"},{"key":"633_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.30131","volume":"69","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Feng D, Ma X, Fan S, Gao Y, Fu K, et al. Pregnane X receptor regulates liver size and liver cell fate by yes-associated protein activation in mice. Hepatology. 2019;69:343\u201358.","journal-title":"Hepatology."},{"key":"633_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.dld.2015.05.011","volume":"47","author":"Q Nguyen","year":"2015","unstructured":"Nguyen Q, Anders RA, Alpini G, Bai H. Yes-associated protein in the liver: Regulation of hepatic development, repair, cell fate determination and tumorigenesis. Dig Liver Dis. 2015;47:826\u201335.","journal-title":"Dig Liver Dis"},{"key":"633_CR19","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17:2054\u201360.","journal-title":"Curr Biol"},{"key":"633_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bph.13729","volume":"174","author":"H Zeng","year":"2017","unstructured":"Zeng H, Jiang Y, Chen P, Fan X, Li D, Liu A, et al. Schisandrol B protects against cholestatic liver injury through pregnane X receptors. Br J Pharmacol. 2017;174:672\u201388.","journal-title":"Br J Pharmacol."},{"key":"633_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1124\/dmd.115.066969","volume":"44","author":"H Zeng","year":"2016","unstructured":"Zeng H, Li D, Qin X, Chen P, Tan H, Zeng X, et al. Hepatoprotective effects of Schisandra sphenanthera extract against lithocholic acid-induced cholestasis in male mice are associated with activation of the pregnane X receptor pathway and promotion of liver regeneration. Drug Metab Dispos. 2016;44:337\u201342.","journal-title":"Drug Metab Dispos"},{"key":"633_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.4158\/EP15760.OR","volume":"21","author":"KC Yuen","year":"2015","unstructured":"Yuen KC, Williams G, Kushner H, Nguyen D. Association between mifepristone dose, efficacy, and tolerability in patients with Cushing syndrome. Endocr Pract. 2015;21:1087\u201392.","journal-title":"Endocr Pract."},{"key":"633_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0304-3835(96)04310-8","volume":"106","author":"P Carthew","year":"1996","unstructured":"Carthew P, Nolan BM, Edwards RE, Smith LL. The role of cell death and cell proliferation in the promotion of rat liver tumours by tamoxifen. Cancer Lett. 1996;106:163\u20139.","journal-title":"Cancer Lett."},{"key":"633_CR24","first-page":"764","volume":"47","author":"CL Li","year":"2012","unstructured":"Li CL, Chen DJ, Sheng XJ, Liu MX, Weng HN, Du PL, et al. The lowest dosages of mifepristone and misoprostol to terminate ultra-early pregnancy. Zhonghua Fu Chan Ke Za Zhi. 2012;47:764\u20138.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"633_CR25","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1111\/jog.13716","volume":"44","author":"LP Song","year":"2018","unstructured":"Song LP, Tang SY, Li CL, Zhou LJ, Mo XT. Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol. J Obstet Gynaecol Res. 2018;44:1705\u201311.","journal-title":"J Obstet Gynaecol Res"},{"key":"633_CR26","first-page":"513","volume":"76","author":"AA Murphy","year":"1993","unstructured":"Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab. 1993;76:513\u20137.","journal-title":"J Clin Endocrinol Metab."},{"key":"633_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/HUMREP\/11.2.256","volume":"11","author":"K Gemzell-Danielsson","year":"1996","unstructured":"Gemzell-Danielsson K, Westlund P, Johannisson E, Swahn ML, Bygdeman M, Seppala M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum Reprod. 1996;11:256\u201364.","journal-title":"Hum Reprod"},{"key":"633_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0002-9378(11)91627-5","volume":"167","author":"MC Batista","year":"1992","unstructured":"Batista MC, Cartledge TP, Zellmer AW, Merino MJ, Axiotis C, Loriaux DL, et al. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy. Am J Obstet Gynecol. 1992;167:60\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"633_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0092-8674(00)81698-0","volume":"95","author":"MD Jacobs","year":"1998","unstructured":"Jacobs MD, Harrison SC. Structure of an IkappaBalpha\/NF-kappaB complex. Cell. 1998;95:749\u201358.","journal-title":"Cell."},{"key":"633_CR30","doi-asserted-by":"publisher","first-page":"17882","DOI":"10.1074\/jbc.M601302200","volume":"281","author":"X Gu","year":"2006","unstructured":"Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, et al. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem. 2006;281:17882\u20139.","journal-title":"J Biol Chem"},{"key":"633_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tips.2012.03.003","volume":"33","author":"J Cheng","year":"2012","unstructured":"Cheng J, Shah YM, Gonzalez FJ. Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci. 2012;33:323\u201330.","journal-title":"Trends Pharmacol Sci"},{"key":"633_CR32","doi-asserted-by":"publisher","first-page":"G1114","DOI":"10.1152\/ajpgi.00528.2006","volume":"292","author":"YM Shah","year":"2007","unstructured":"Shah YM, Ma X, Morimura K, Kim I, Gonzalez FJ. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1114\u201322.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"633_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1248\/bpb.35.473","volume":"35","author":"N Moriya","year":"2012","unstructured":"Moriya N, Kataoka H, Fujino H, Nishikawa J, Kugawa F. Effect of lipopolysaccharide on the xenobiotic-induced expression and activity of hepatic cytochrome P450 in mice. Biol Pharm Bull. 2012;35:473\u201380.","journal-title":"Biol Pharm Bull"},{"key":"633_CR34","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/hep.22475","volume":"48","author":"WE Blanco-Bose","year":"2008","unstructured":"Blanco-Bose WE, Murphy MJ, Ehninger A, Offner S, Dubey C, Huang W, et al. C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia. Hepatology. 2008;48:1302\u201311.","journal-title":"Hepatology."},{"key":"633_CR35","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","volume":"133","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710\u20135.","journal-title":"J Immunol"},{"key":"633_CR36","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/hep.24111","volume":"53","author":"A Thenappan","year":"2011","unstructured":"Thenappan A, Shukla V, Abdul Khalek FJ, Li Y, Shetty K, Liu P, et al. Loss of transforming growth factor beta adaptor protein beta-2 spectrin leads to delayed liver regeneration in mice. Hepatology. 2011;53:1641\u201350.","journal-title":"Hepatology."},{"key":"633_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1152\/physrev.1989.69.3.708","volume":"69","author":"K Jungermann","year":"1989","unstructured":"Jungermann K, Katz N. Functional specialization of different hepatocyte populations. Physiol Rev. 1989;69:708\u201364.","journal-title":"Physiol Rev"},{"key":"633_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature21065","volume":"542","author":"KB Halpern","year":"2017","unstructured":"Halpern KB, Shenhav R, Matcovitch-Natan O, Toth B, Lemze D, Golan M, et al. Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature. 2017;542:352\u20136.","journal-title":"Nature."},{"key":"633_CR39","doi-asserted-by":"crossref","unstructured":"Maglich JM, Sluder A, Guan X, Shi Y, McKee DD, Carrick K, et al. Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol. 2001;2:RESEARCH0029.","DOI":"10.1186\/gb-2001-2-8-research0029"},{"key":"633_CR40","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1124\/dmd.31.11.1296","volume":"31","author":"S Teng","year":"2003","unstructured":"Teng S, Jekerle V, Piquette-Miller M. Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab Dispos. 2003;31:1296\u20139.","journal-title":"Drug Metab Dispos"},{"key":"633_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpba.2018.03.008","volume":"154","author":"W Chen","year":"2018","unstructured":"Chen W, Xiao Y, Cheng Y, Chen J, Chen J, Jiang K, et al. Pharmacokinetic differences of mifepristone between sexes in animals. J Pharm Biomed Anal. 2018;154:108\u201315.","journal-title":"J Pharm Biomed Anal."},{"key":"633_CR42","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747\u201361.","journal-title":"Genes Dev"},{"key":"633_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.210773.112","volume":"27","author":"FX Yu","year":"2013","unstructured":"Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev. 2013;27:355\u201371.","journal-title":"Genes Dev"},{"key":"633_CR44","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1124\/mol.63.3.524","volume":"63","author":"K Kawana","year":"2003","unstructured":"Kawana K, Ikuta T, Kobayashi Y, Gotoh O, Takeda K, Kawajiri K. Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol Pharmacol. 2003;63:524\u201331.","journal-title":"Mol Pharmacol"},{"issue":"Suppl 1","key":"633_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1289\/ehp.98106s1289","volume":"106","author":"JE Klaunig","year":"1998","unstructured":"Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 1998;106(Suppl 1):289\u201395.","journal-title":"Environ Health Perspect."},{"key":"633_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/01926230252824699","volume":"30","author":"GM Williams","year":"2002","unstructured":"Williams GM, Iatropoulos MJ. Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity. Toxicol Pathol. 2002;30:41\u201353.","journal-title":"Toxicol Pathol"},{"key":"633_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/03602532.2012.743560","volume":"45","author":"MW Sinz","year":"2013","unstructured":"Sinz MW. Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development. Drug Metab Rev. 2013;45:3\u201314.","journal-title":"Drug Metab Rev"},{"key":"633_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.apsb.2016.07.016","volume":"6","author":"WD Hedrich","year":"2016","unstructured":"Hedrich WD, Hassan HE, Wang H. Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B. 2016;6:413\u201325.","journal-title":"Acta Pharm Sin B"},{"key":"633_CR49","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1538-7836.2010.04036.x","volume":"8","author":"A Rulcova","year":"2010","unstructured":"Rulcova A, Prokopova I, Krausova L, Bitman M, Vrzal R, Dvorak Z, et al. Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes. J Thromb Haemost. 2010;8:2708\u201317.","journal-title":"J Thromb Haemost"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00633-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00633-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00633-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T09:00:01Z","timestamp":1698138001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00633-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00633-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}